A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
Recruiting · NCT05217693 · Registry updated 2025-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2025-07-24 | NCT05217693 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 85 |
| Bliss Biopharmaceutical Co, Ltd | Hangzhou | China | 1 |
| First Affiliated Hospital of Gannan Medical University | Ganzhou | China | 5 |
| Hunan Cancer Hospital | Changsha | China | 47 |
| Jiangsu Province Hospital | Nanjing | China | 39 |
| Linyi Cancer Hospital | Linyi | China | 19 |
| Zhejiang University School of Medicine - The First Affiliated Hospital | Hanzhou | China | 1 |